Type 2 diabetes originated from non-alcoholic fatty liver disease

被引:6
作者
Xiong, Xuelian [1 ]
Li, Xiaoying [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200032, Peoples R China
来源
LIFE METABOLISM | 2023年 / 2卷 / 01期
基金
中国国家自然科学基金;
关键词
non-alcoholic fatty liver disease; gluconeogenesis; hepatokine; exercise; HEPATIC STEATOSIS; ASSOCIATION; RECEPTOR; OBESITY;
D O I
10.1093/lifemeta/load007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Both non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are highly prevalent metabolic liver diseases. Accumulating epidemiological evidence now indicates that NAFLD and T2DM are strongly associated, yet the causative relationship remains to be elucidated. Liver serves as a hub for nutrient and energy metabolism in the body. Here we demonstrated the pathogenesis linking NAFLD to T2DM through a series of studies and the attenuation of T2DM progression after NALFD improvement in cohort study. We proposed the urgent necessity of NAFLD management and NAFLD drug development, which might be novel therapeutic avenues for T2DM.
引用
收藏
页数:3
相关论文
共 23 条
[1]   Effect of Moderate and Vigorous Aerobic Exercise on Incident Diabetes in Adults With Obesity A 10-Year Follow-up of a Randomized Clinical Trial [J].
Chen, Ying ;
Chen, Zheng ;
Pan, Lingling ;
Ma, Zhi-Min ;
Zhang, Huijie ;
Li, Xue-Jun ;
Li, Xiaoying .
JAMA INTERNAL MEDICINE, 2023, 183 (03) :272-275
[2]   Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications [J].
Fabbrini, Elisa ;
Sullivan, Shelby ;
Klein, Samuel .
HEPATOLOGY, 2010, 51 (02) :679-689
[3]   Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus [J].
Ferguson, Daniel ;
Finck, Brian N. .
NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (08) :484-495
[4]   Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data [J].
Goldenberg, Joshua Z. ;
Day, Andrew ;
Brinkworth, Grant D. ;
Sato, Junko ;
Yamada, Satoru ;
Jonsson, Tommy ;
Beardsley, Jennifer ;
Johnson, Jeffrey A. ;
Thabane, Lehana ;
Johnston, Bradley C. .
BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
[5]   Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial [J].
Holmer, Magnus ;
Lindqvist, Catarina ;
Petersson, Sven ;
Moshtaghi-Svensson, John ;
Tillander, Veronika ;
Brismar, Torkel B. ;
Hagstrom, Hannes ;
Stal, Per .
JHEP REPORTS, 2021, 3 (03)
[6]   Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies [J].
Jarvis, Helen ;
Craig, Dawn ;
Barker, Robert ;
Spiers, Gemma ;
Stow, Daniel ;
Anstee, Quentin M. ;
Hanratty, Barbara .
PLOS MEDICINE, 2020, 17 (04)
[7]   Sustained ER stress promotes hyperglycemia by increasing glucagon action through the deubiquitinating enzyme USP14 [J].
Liu, Bin ;
Zhang, Zhijian ;
Hu, Yanyun ;
Lu, Yan ;
Li, Duanzhuo ;
Liu, Jie ;
Liao, Shengjie ;
Hu, Min ;
Wang, Yuxing ;
Zhang, Die ;
Chen, Yulu ;
Qian, Qilan ;
Lv, Xianfeng ;
Wu, Duojiao ;
Tan, Minjia ;
Hu, Cheng ;
Xiong, Xuelian ;
Li, Xiaoying .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (43) :21732-21738
[8]   Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis [J].
Loomba, Rohit ;
Abraham, Maria ;
Unalp, Aynur ;
Wilson, Laura ;
Lavine, Joel ;
Doo, Ed ;
Bass, Nathan M. .
HEPATOLOGY, 2012, 56 (03) :943-951
[9]   Obesity-induced excess of 17-hydroxyprogesterone promotes hyperglycemia through activation of glucocorticoid receptor [J].
Lu, Yan ;
Wang, E. ;
Chen, Ying ;
Zhou, Bing ;
Zhao, Jiejie ;
Xiang, Liping ;
Qian, Yiling ;
Jiang, Jingjing ;
Zhao, Lin ;
Xiong, Xuelian ;
Lu, Zhiqiang ;
Wu, Duojiao ;
Liu, Bin ;
Yan, Jing ;
Zhang, Rong ;
Zhang, Huijie ;
Hu, Cheng ;
Li, Xiaoying .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (07) :3791-3804
[10]   Periostin promotes liver steatosis and hypertriglyceridernia through dovvnregulation of PPARα [J].
Lu, Yan ;
Liu, Xing ;
Jiao, Yang ;
Xiong, Xuelian ;
Wang, E. ;
Wang, Xiaolin ;
Zhang, Zhijian ;
Zhang, Huijie ;
Pan, Lingling ;
Guan, Youfei ;
Cai, Dongsheng ;
Ning, Guang ;
Li, Xiaoying .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (08) :3501-3513